NCT05040113

A Study On Human Mass Balance And Biotransformation

A Clinical Study to Evaluate Absorption, Metabolism and Excretion of [14C] CBP-307 in Healthy Chinese Male Adult Subjects - Human Mass Balance and Biotransformation Study of [14C] CBP-307

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Connect Biopharm LLC · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study will evaluate the absorption,metabolism and excretion of CBP-307 in healthy chinese male subjects.

Conditions

• Healthy Adult Subjects

Interventions

Type	Name	Description
DRUG	CBP-307	CBP-307 capsules oral administration

Timeline

• Start date: 2021-09-04
• Primary completion: 2021-10-30
• Completion: 2021-10-30
• First posted: 2021-09-10
• Last updated: 2022-04-05

Locations

1 site across 1 country: China

Regulatory

• FDA-regulated drug study